Novel glucagon-like peptide-1 (GLP-1) analog (Val<sup>8</sup>)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (<i>ob/ob</i>) mice.


Autoria(s): Green, Brian; Flatt, P.R.; Lavery, K.; Irwin, N.; O'Harte, F.P.M.; Harriott, Patrick; Greer, Brett; Bailey, C.J.
Data(s)

01/04/2006

Identificador

http://pure.qub.ac.uk/portal/en/publications/novel-glucagonlike-peptide1-glp1-analog-val8glp1-results-in-significant-improvements-of-glucose-tolerance-and-pancreatic-betacell-function-after-3week-daily-administration-in-obese-diabetic-obob-mice(c261aa83-6072-4ab0-9aa6-9891420fcbc8).html

http://dx.doi.org/10.1124/jpet.105.097824

http://www.scopus.com/inward/record.url?scp=33745937115&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Green , B , Flatt , P R , Lavery , K , Irwin , N , O'Harte , F P M , Harriott , P , Greer , B & Bailey , C J 2006 , ' Novel glucagon-like peptide-1 (GLP-1) analog (Val 8 )GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic ( ob/ob ) mice. ' Journal of Pharmacology and Experimental Therapeutics , vol 318(2) , no. 2 , pp. 914-921 . DOI: 10.1124/jpet.105.097824

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/3000/3004 #Pharmacology
Tipo

article